RxDoctor Payments Data

Gabriella Rosil

Family · Orange, CANPI 1073147963

Payments from drug & device makers

$2,366in general payments, 2019–2025

Across 105 payments — averaging $22.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$305
  • Lilly USA, LLC$287
  • Novo Nordisk$238
  • AstraZeneca$234
  • Amgen$186
  • GSK$170
  • plus $947 from 14 others

What the payments were for

  • Food & beverage$2,366100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,366 in reported general payments places this provider in the 85th percentile of 10,634 family providers in California.

See all family providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
Atorvastatin Calcium67$804
Albuterol Sulfate HfaAlbuterol Sulfate31$776
Losartan Potassium60$600
Levothyroxine Sodium27$525
Metformin Hcl54$492
Lisinopril31$301
Omeprazole27$290
Rosuvastatin Calcium19$244
Amlodipine Besylate45$148
Fluticasone Propionate20$137
Enalapril Maleate15$130
Gabapentin13$127
Doxycycline Hyclate20$120
Clotrimazole17$116
Glipizide11$77

Paid to pharmacies, not to this prescriber.

Other family in Orange

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →